Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY

Amy Schulman received 838 Alnylam Pharmaceuticals, Inc. shares as an award (Form 4)

Traded May 20, 2026 · Filed May 22, 2026

On May 20, 2026, Amy Schulman (Director) received 838 Alnylam Pharmaceuticals, Inc. shares as an award, leaving 24,049 shares. Filed May 22, 2026 (Form 4).

Awarded
838 shares
Holding after
24,049 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockAward83824,049Direct

Source

View original at SEC

Related